Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. National Comprehensive Cancer Network (2023) NCCN clinical practice guidelines in oncology (NCCN Guidelines®) Non-small cell lung cancer, Version 3.2023 [Internet]. National Comprehensive Cancer Network. p. Version 3. Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf
2. Gierman HJ, Pai N, Catasus C, Tam A, Labrador M, Donaldson J, et al. A retrospective three-year analysis using real-world data on uptake of broad-based NextGen sequencing panels in community oncology practices. J Clin Oncol. 2020;38(15_suppl):e13668–e13668. https://doi.org/10.1200/JCO.2020.38.15_suppl.e13668.
3. Paz-Ares L, Gondos A, Saldana D, Thomas M, Mascaux C, Bubendorf L, et al. Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: a contemporary clinical practice patterns study. Lung Cancer. 2022;167(October 2021):41–8. https://doi.org/10.1016/j.lungcan.2022.01.021.
4. de Moor JS, Gray SW, Mitchell SA, Klabunde CN, Freedman AN. Oncologist confidence in genomic testing and implications for using multimarker tumor panel tests in practice. JCO Precis Oncol. 2020;4:620–31.
5. Mileham KF, Schenkel C, Bruinooge SS, Freeman-Daily J, Basu Roy U, Moore A, et al. Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: results of a survey of U.S. oncologists. Cancer Med. 2022;11(2):530–8.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献